共 136 条
[1]
Ajani JA(2006)A multi-center phase II study of sequential paclitaxel and bryostatin-1 (NSC 339555) in patients with untreated, advanced gastric or gastroesophageal junction adenocarcinoma Invest New Drugs 24 353-357
[2]
Jiang Y(1995)Inhibition of leukemic cell growth by the protein kinase C activator bryostatin 1 correlates with the dephosphorylation of cyclin-dependent kinase 2 Cancer Res 55 3716-3720
[3]
Faust J(2003)Esophageal cancer N Engl J Med 349 2241-2252
[4]
Chang BB(1993)Effects of cisplatin on the induction of apoptosis in proliferating hepatoma cells and nonproliferating immature thymocytes Cancer Res 53 2133-2139
[5]
Ho L(1992)Potentiation of the activity of 1–beta- Cancer Res 52 6270-6278
[6]
Yao JC(1994)-arabinofuranosylcytosine by the protein kinase C activator bryostatin 1 in HL–60 cells: association with enhanced fragmentation of mature DNA J Exp Med 180 525-535
[7]
Rousey S(1987)Ionizing radiation acts on cellular membranes to generate ceramide and initiate apoptosis Carcinogenesis 8 1343-1346
[8]
Dakhil S(1995)Bryostatin 1, an activator of protein kinase C, inhibits tumor promotion by phorbol esters in SENCAR mouse skin Br J Cancer 72 998-1003
[9]
Cherny RC(2007)Bryostatin 1, a novel antineoplastic agent and protein kinase C activator, induces human myalgia and muscle metabolic defects: a 31P magnetic resonance spectroscopic study Ann Oncol 18 898-902
[10]
Craig C(1994)Paclitaxel given by a weekly 1-h infusion in advanced esophageal cancer J Biol Chem 269 31685-31692